Healthcare company RoseRx has appointed Aurélie Cornu as vice president of marketing, bringing experience from ASX-listed SiteMinder, Lighthouse, and Goodstack. She will lead RoseRx’s global marketing strategy as the company broadens its footprint and strengthens its service offering to global pharma partners.
The life science commercialisation technology platform uses AI to deliver personalised digital engagement solutions for pharmaceutical, medical device, and diagnostic companies. Its solutions help healthcare brands connect more effectively with patients and professionals across multiple channels while maintaining compliance.
Rob Wise has also joined as lead AI engineer and will focus on scaling RoseRx’s proprietary AI technology to create compliant digital engagement tools that support patients and clinicians navigating complex healthcare decisions.
RoseRx CEO and co-founder Romain Bonjean said the appointments reflect the company’s ambition to maintain its lead in AI-driven healthcare communication.
“Aurélie and Rob bring crucial expertise that will help build on our momentum and continue delivering solutions that help connect life sciences companies, clinicians, and patients in powerful new ways.”
“RoseRx sits at the intersection of healthcare, technology, and innovation. I’m excited to join at such a pivotal time as we extend our reach into new markets and scale our AI-powered solutions globally,” commented Cornu on her appointment.
